Product
Dubermatinib
1 clinical trial
2 indications
Indication
Acute Myeloid LeukemiaIndication
Therapy-Related Acute Myeloid LeukemiaClinical trial
A Phase 1b/2 Study of TP-0903 in Patients With Acute Myeloid Leukemia and FLT3 MutationsStatus: Completed, Estimated PCD: 2021-10-13